Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

Author： Cosentino-Boehm Abby L.   Lafky Jacqueline M.   Greenwood Tammy M.   Kimbler Kimberly D.   Buenafe Marites C.   Wang Yuxia   Branscum Adam J.   Yang Ping   Maihle Nita J.   Baron Andre T.  

Publisher： MDPI

E-ISSN： 2075-4418|3|1|13-32

ISSN： 2075-4418

Source： Diagnostics, Vol.3, Iss.1, 2013-01, pp. : 13-32

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy

By Ng Zhi Xiang   Chua Kek Heng   Iqbal Tajunisah   Kuppusamy Umah Rani  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7480-7491

MDPI

Access to resources Recommend Favorite

Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis

By Rau Kun-Ming   Chen Han-Ku   Shiu Li-Yen   Chao Tsai-Ling   Lo Yi-Ping   Wang Chin-Chou   Lin Meng-Chih   Huang Chao-Cheng  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 524-524

MDPI

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 108-114

Karger

Access to resources Recommend Favorite

GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

By  

Chemotherapy, Vol. 62, Iss. 1, 2016-06 ,pp. : 30-33

Karger

Access to resources Recommend Favorite

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

By Chang Shih-Chieh   Chang Cheng-Yu   Shih Jin-Yuan  

Cancers, Vol. 3, Iss. 2, 2011-06 ,pp. : 2667-2678

MDPI

Access to resources Recommend Favorite